CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RIGL

Phase 2

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
RIGLPhase 2

Olutasidenib Phase 2 Est. Readout

Olutasidenib
Q3 2027~Q
CT.gov
00%
Q2 '27
RIGLPhase 2

Olutasidenib Phase 2 Est. Readout

Olutasidenib
Q2 2027~Q
CT.gov
00%
Competitive Landscape

0 competitors in Targeted Therapy

View Full Landscape
Drug Information

Target Indication

Targeted Therapy

Clinical Trial

NCT07032727

Last updated: 10/17/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.